Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the Phantom X System, an implantable electromyography EMG sensor array designed to help control upper-limb prostheses, in individuals with unilateral transradial amputation or wrist disarticulation. This early-feasibility, single-group, open-label study aims to assess the safety, surgical feasibility, device function, signal quality, and ability of the system to support intuitive myoelectric prosthetic control during functional tasks. Participants will undergo surgical implantation of the Phantom X EMG sensor array and telemetry module. After implantation, the device will be activated, calibrated, and integrated with a compatible prosthetic hand. The study includes a series of in-clinic visits to evaluate EMG signal quality and the functional performance of the system using standardized assessments. Patient-reported outcomes such as quality of life and user experience will also be collected. Safety will be monitored through adverse event reporting and system performance checks. During the study, participants will attend multiple visits to complete functional assessments like the Assessment of Capacity for Myoelectric Control ACMC and the Targeted Box and Blocks Test tBBT. Researchers will measure safety up to 9 and 21 weeks after implantation, along with device performance metrics including signal-to-noise ratio, gesture accuracy, prosthesis control resolution, recalibration events, at-home wear duration, and user satisfaction. The total participant involvement lasts at least 21 weeks following implantation to monitor safety and system functionality.
Actively Recruiting
This research aims to assess the long-term safety and effectiveness of the Rigicon Infla 10 Three-Piece Inflatable Penile Prosthesis in men with erectile dysfunction ED. ED is a common male sexual dysfunction linked to various health conditions and affects quality of life. The study follows patients implanted with this device for up to three years to evaluate outcomes. Participants will receive the Rigicon Infla 10 inflatable penile prosthesis as a treatment for ED. After implantation, subjects will be followed according to the study protocol and standard care for ED and related health issues. Follow-up visits are scheduled at 14 days, 6 weeks, 6 months, 12 months, 18 months, 24 months, and 36 months post-procedure. During the study, participants will undergo assessments including safety monitoring for device- or procedure-related adverse events, an objective test of penile rigidity at 12 months, and evaluations of erectile function and self-esteem over time. Researchers will also track durability of the device and collect questionnaire responses. The full participation period may extend up to three years after implantation.